Paradeep Phosphates Ltd

Q4 FY27 Earnings Call Analysis

Fertilizers & Agrochemicals

Full Stock Analysis
capex: Yesrevenue: Category 2margin: Category 3orderbook: No informationfundraise: Yes
💰

fundraise

Any current/future new fundraising through debt or equity?

- The company plans to maintain its gross debt at around 0.75 times of equity and does not intend to increase leverage further. - Gross debt is expected to hover around the same level, approximately 0.3x of equity. - Current gross debt stands at around INR 5,400 crores after netting off investments. - Management aims to control and potentially reduce debt through operational measures such as tighter inventory management. - No explicit mention of new fundraising through equity or increase in debt was made. - Regarding capex funding, ongoing projects have utilized existing funds; future budgets include INR 350 crores for maintenance capex in FY27. - Discussions on cost optimization and credit rating upgrades suggest no immediate need for new fundraising.
🏗️

capex

Any current/future capex/capital investment/strategic investment?

- FY26 capex: INR 500 crores (INR 450 crores already spent in FY25 and FY26, plus INR 50 crores planned). - FY27 maintenance capex budget: INR 350 crores. - Ongoing expansion capex includes: - Granulation unit: ~INR 800 crores. - Phosphoric acid (300,000 tons): ~INR 800-900 crores. - Combined phosphoric and sulphuric acid expansion: ~INR 1,500 crores (INR 800 crores for phosphoric acid and remainder for sulphuric acid). - Energy efficiency project at Goa site: INR 220 crores investment expected to reduce energy consumption from 6.4 to 6.1 Gcal/ton, with a 3-4 year payback. - Phosphoric acid expansion of 0.2 million tons planned for Q2 FY27. - Sulphuric acid expansion of 0.1 million tons at Mangalore targeted for FY27. - Sulphuric acid 0.03 million tons addition commissioned in FY26 (Sept end).
📊

revenue

Future growth expectations in sales/revenue/volumes?

- FY26 volume guidance is around 4 million tons plus, up from 3 million tons last year (3.38 million tons already achieved). - For FY27, the company plans robust volume growth, focusing on optimizing and strengthening the NPK portfolio mix. - Expect continued growth in value-added NPK grades, which have shown a 30% YTD growth. - Capacity expansions in phosphoric acid (from 0.5 to 0.7 million tons) and sulphuric acid planned for FY27 to support volume growth. - Incremental EBITDA expected from backward integration projects and increased processing capacity, improving earnings quality. - The company is expanding granulation capacity at Paradeep from 1.8 million to 2 million tons. - Management remains optimistic about fertilizer demand driven by government focus on soil health and balanced nutrient application. - Strategic expansion will deepen market presence and economies of scale, supporting long-term growth.
📈

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

- Expect incremental EBITDA addition of around INR 350-360 crores next year due to backward integration and completed projects (Page 16). - Sustainable EBITDA per ton likely to improve by 30-35% once all sites achieve 100% backward integration (Page 13). - Long-term EBITDA margin guidance around 11%, maintaining current levels post-merger and capacity expansion (Page 15). - FY27 EBITDA per ton targeted around INR 4,500 to INR 5,000, subject to raw material prices and subsidy policy outcomes (Page 8). - Volume expected to grow robustly; FY26 guidance is 4 million+ tons, building on 3 million tons last year (Page 9). - Continuous efforts to optimize product mix towards higher-margin NPK fertilizers will aid earnings quality (Pages 7 and 16). - Debt levels to be maintained prudently (gross debt around 0.75x equity) to support expansion without excessive leverage (Page 16).
📋

orderbook

Current/ Expected Orderbook/ Pending Orders?

The provided transcript and presentation of Paradeep Phosphates Limited's Q3 & 9M FY26 earnings call do not explicitly mention details about the current or expected order book or pending orders. The discussion primarily focuses on: - Production and capacity expansions (phosphoric and sulphuric acid plants) - EBITDA guidance and margin outlook - Debt and capex details - Subsidy receivables and government policy impacts - Market demand and product mix strategy No specific figures or commentary related to the order book or pending orders are disclosed in the available pages, including page 16.